Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway

Cancer Letters

Volumn 281, Issue 2, 2009, Pages 213-219

  Ouyang, Gaoliang ^a   Liu, Min ^a   Ruan, Kai ^a   Song, Gang ^a,b   Mao, Yubin ^a   Bao, Shideng ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Cell survival; Hypoxia; Periostin

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR ALPHA; UP-REGULATION;

EID: 67349256386     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.030     Document Type: Article

References (33)

1. Hu M., and Polyak K. Microenvironmental regulation of cancer development. Curr. Opin. Genet. Dev. 18 (2008) 27-34
2. Bissell M.J., and Radisky D. Putting tumours in context. Nat. Rev. Cancer 1 (2001) 46-54
3. Radisky D., Hagios C., and Bissell M.J. Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 11 (2001) 87-95
4. Bristow R.G., and Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 8 (2008) 180-192
5. Pouyssegur Dayan J.F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
6. Bao S., Ouyang G., Bai X., Huang Z., Ma C., Liu M., Shao R., Anderson R.M., Rich J.N., and Wang X.F. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5 (2004) 329-339
7. Takeshita S., Kikuno R., Tezuka K., and Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294 (1993) 271-278
8. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L.F., and Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14 (1999) 1239-1249
9. Sasaki H., Lo K.M., Chen L.B., Auclair D., Nakashima Y., Moriyama S., Fukai I., Tam C., Loda M., and Fujii Y. Expression of periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn. J. Cancer Res. 92 (2001) 869-873
10. Sasaki H., Dai M., Auclair D., Fukai I., Kiriyama M., Yamakawa Y., Fujii Y., and Chen L.B. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92 (2001) 843-848
11. Soltermann A., Tischler V., Arbogast S., Braun J., Probst-Hensch N., Weder W., Moch H., and Kristiansen G. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 14 (2008) 7430-7437
12. Gillan L., Matei D., Fishman D.A., Gerbin C.S., Karlan B.Y., and Chang D.D. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62 (2002) 5358-5364
13. Siriwardena B.S., Kudo Y., Ogawa I., Kitagawa M., Kitajima S., Hatano H., Tilakaratne W.M., Miyauchi M., and Takata T. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br. J. Cancer 95 (2006) 1396-1403
14. Kudo Y., Ogawa I., Kitajima S., Kitagawa M., Kawai H., Gaffney P.M., Miyauchi M., and Takata T. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 66 (2006) 6928-6935
15. Kudo Y., Siriwardena B.S., Hatano H., Ogawa I., and Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol. Histopathol. 22 (2007) 1167-1174
16. Shao R., Bao S., Bai X., Blanchette C., Anderson R.M., Dang T., Gishizky M.L., Marks J.R., and Wang X.F. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 24 (2004) 3992-4003
17. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
18. Li P., Oparil S., Feng W., and Chen Y.F. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J. Appl. Physiol. 97 (2004) 1550-1558 discussion 1549
19. Bos M., Mendelsohn J., Kim Y.M., Albanell J., Fry D.W., and Baselga J. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin. Cancer Res. 3 (1997) 2099-2106
20. Gunaratnam L., Morley M., Franovic A., de Paulsen N., Mekhail K., Parolin D.A., Nakamura E., Lorimer I.A., and Lee S. Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J. Biol. Chem. 278 (2003) 44966-44974
21. Raffioni S., and Bradshaw R.A. Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. Proc. Natl .Acad. Sci. USA 89 (1992) 9121-9125
22. Hadari Y.R., Gotoh N., Kouhara H., Lax I., and Schlessinger J. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. USA 98 (2001) 8578-8583
23. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9 (2005) 59-71
24. Shi Q., Bao S., Maxwell J.A., Reese E.D., Friedman H.S., Bigner D.D., Wang X.F., and Rich J.N. Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J. Biol. Chem. 279 (2004) 52200-52209
25. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
26. Hahn W.C., and Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2 (2002) 331-341
27. Lopez-Maury L., Marguerat S., and Bahler J. Tuning gene expression to changing environments: from rapid responses to evolutionary adaptation. Nat. Rev. Genet. 9 (2008) 583-593
28. Tateishi M., Ishida T., Mitsudomi T., Kaneko S., and Sugimachi K. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res. 50 (1990) 7077-7080
29. Brattstrom D., Bergqvist M., Hesselius P., Larsson A., Wagenius G., and Brodin O. Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer. Lung Cancer 43 (2004) 55-62
30. Powis G., and Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Mol. Cancer Ther. 3 (2004) 647-654
31. Song G., Cai Q.F., Mao Y.B., Ming Y.L., Bao S.D., and Ouyang G.L. Osteopontin promotes ovarian cancer progression and cell survival and increase HIF-1alpha expression through the PI3-K/Akt pathway. Cancer Sci. 99 (2008) 1901-1907
32. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem. 132 (2002) 359-371
33. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2 (2002) 584-593